Red light treatment for improving blood flow in peripheral artery disease
Official title: Vasodilatory Effects of Light on Peripheral Artery Disease
Run by University of Alabama at Birmingham · NCT03203239 · Data updated 2026-11-12
This study is testing if a short exposure to red light can improve blood flow in the legs of people with peripheral artery disease.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 85 Years |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | University of Alabama at Birmingham Academic / other |
| Locations | 1 site (Milwaukee, Wisconsin) |
| Status | Recruiting |
| Started | January 17, 2018 |
| Main results expected | December 31, 2028 |
| Study ends | December 31, 2028 |
| Registry record updated | May 1, 2026 |
| Trial ID | NCT03203239 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 to 85 diagnosed with peripheral artery disease, as indicated by an abnormal ankle-brachial index.
✕Probably not a fit
Patients under 18 or over 85, those with certain medical conditions, or those unable to understand the consent process may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the effects of a single 5-minute exposure to 670 nm red light on blood flow in the gastrocnemius muscle of patients diagnosed with peripheral artery disease. Participants will undergo blood flow measurement using contrast-enhanced ultrasound before and after the light exposure, along with blood samples collected to assess nitric oxide metabolites. The study aims to determine if this non-invasive treatment can enhance vasodilation and improve circulation in affected individuals. It is designed to be completed in one visit, with a possibility of a second visit if data quality requires it.
Why it matters
Potential benefit: If successful, this treatment could provide a novel, non-invasive method to improve blood flow and alleviate symptoms in patients with peripheral artery disease.
How similar studies have gone: While the use of red light therapy is gaining interest, this specific approach in peripheral artery disease is relatively novel and has not been extensively tested in prior studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Participants will be subjects between the ages of 18 and 85 who have been diagnosed with peripheral artery disease. Men and women will be recruited for participation. All ethnicities will be included in this study. Diagnosis of peripheral artery disease is defined as an Ankle Brachial index of \<0.9 or greater than 1.1 either at rest or during treadmill exercise. Exclusion Criteria: * Exclusionary criteria include age under 18 years and over 85 years, those who are unable to understand the consent process , those who cannot read or speak English, active pregnancy, hypersensitivity to perflutren contrast agents, pulmonary hypertension, active illicit drug use, untreated blood pressure over 160/95, sickle cell disease, or a history of intracardiac shunt. Additional exclusion criteria neurological diseases such as spinal stenosis, unspecified pain disorders, and any uncontrolled medical conditions.
Where it's running
-
Medical College of Wisconsin
Milwaukee, Wisconsin, United States Recruiting
Study contacts
- Principal investigator: Nicole L Lohr, MD,PHD — Medical College of Wisconsin
- Study coordinator: Nicole L Lohr, MD,PHD
- Email: nlohr@uabmc.edu
- Phone: 414-996-3504
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Calf stretching therapy for improving health in patients with peripheral artery disease
This study is testing if using inflatable ankle splints to stretch calf muscles can help people with peripheral artery disease walk better and improve their leg health.
-
Antiplatelet-Only versus Antiplatelet plus Low-Dose Rivaroxaban after Heart Events
In adults 65 or older with prior heart events and certain arterial diseases, this study tests whether continuing clopidogrel alone is no worse than adding low-dose rivaroxaban to aspirin-based therapy.
-
Home-based Pedal Exerise Therapy for Moderate-to-Severe PAD
This pilot study tests whether a 12-week home-based pedal exerciser program, guided remotely, can help adults with moderate-to-severe PAD improve walking and function.
-
Super-resolution ultrasound imaging for peripheral artery disease
This project will test whether super-resolution contrast ultrasound can reveal small-vessel problems in adults with or without peripheral artery disease.
-
Obstructive sleep apnea prevalence in people with peripheral artery disease
This project will test how common obstructive sleep apnea is in adults with peripheral artery disease by using sleep polygraphy during routine care.
-
Using wearable activity trackers and a mobile app to help people with peripheral artery disease walk better
This project will test whether a personalized home walking program guided by wearable activity trackers and automatic feedback can help people with peripheral artery disease walk as well as supervised exercise sessions.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.